adenosine monophosphate has been researched along with Insulin Resistance in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Cheng, J; Guan, F; Huang, X; Li, M; Li, Y; Lin, G; Liu, Y; Ma, X; Su, Z; Xie, J; Xu, L; Yu, Q | 1 |
| Fujita, K; Goto, T; Inoue, K; Ishikawa, F; Jinno, T; Kyo, S; Matsumura, S; Miyakita, M; Miyamori, H; Momma, K; Sasaki, T; Takenaka, S; Tanaka, J; Yokokawa, T | 1 |
| Cheng, J; Guan, F; Huang, Z; Li, M; Lin, G; Liu, Y; Ma, X; Su, Z; Xie, Q; Yan, F; Yan, G; Yu, Q | 1 |
| Cheng, J; Morisaki, H; Morisaki, T; Wang, Q; Xi, Y; Yang, H; Yu, W | 1 |
| Fang, Z; Wu, Y; Yin, Y; You, L | 1 |
| Brobst, D; Chan, CB; Chow, BKC; Herlea-Pana, O; Hu, X; Lee, CW; Liu, Z; Tse, MCL; Wood, J; Yang, X; Ye, K; Zaw, AM | 1 |
| Huang, F; Liu, BL; Liu, K; Wang, JL; Yang, JL | 1 |
| Cheng, S; He, J; Jiang, C; Jiang, W; Kuang, J; Liu, Q; Mo, L; Pu, S; Qu, A; Shen, J; Zhang, Y; Zou, M | 1 |
| Gugliucci, A | 2 |
| Chi, MM; Louden, E; Moley, KH | 1 |
| Bourron, O; Daval, M; Ferré, P; Foufelle, F; Gautier, JF; Hainault, I; Hajduch, E; Servant, JM | 1 |
| Ichida, K | 1 |
| Hua, Z; Wang, S; Wang, Z; Zhang, J; Zhang, Y; Zhao, M; Zhao, Y | 1 |
| Andreelli, F; Vaulont, S; Viollet, B | 1 |
| Chusho, H; Ebihara, K; Fujimoto, M; Hayashi, T; Hidaka, S; Hosoda, K; Kobayashi, N; Kusakabe, T; Masuzaki, H; Minokoshi, Y; Miyanaga, F; Nakao, K; Ogawa, Y; Sakata, T; Sato, K; Tanaka, T; Tanioka, H; Tomita, T; Toyoda, T; Yasue, S; Yoshimatsu, H | 1 |
| Gao, Z; Liu, D; Liu, Z; Ye, J; Yin, J | 1 |
1 review(s) available for adenosine monophosphate and Insulin Resistance
| Article | Year |
|---|---|
[Hyperuricemia and metabolic syndrome].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Fructose; Humans; Hyperuricemia; Insulin Resistance; Kidney Tubules; Liver; Metabolic Syndrome; NADP; Obesity; Organic Anion Transporters; Organic Cation Transport Proteins; Purines; Sodium; Uric Acid | 2010 |
16 other study(ies) available for adenosine monophosphate and Insulin Resistance
| Article | Year |
|---|---|
Metformin alleviates long-term high-fructose diet-induced skeletal muscle insulin resistance in rats by regulating purine nucleotide cycle.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylosuccinate Synthase; AMP-Activated Protein Kinases; Animals; Antioxidants; Diet; Fructose; Insulin; Insulin Resistance; Metabolic Syndrome; Metformin; Muscle, Skeletal; NF-E2-Related Factor 2; Purine Nucleotides; Rats | 2022 |
CRTC1 deficiency, specifically in melanocortin-4 receptor-expressing cells, induces hyperphagia, obesity, and insulin resistance.
Topics: Adenosine Monophosphate; Animals; Energy Metabolism; Glucose; Humans; Hyperphagia; Insulin Resistance; Mice; Mice, Knockout; Obesity; Receptor, Melanocortin, Type 4; Transcription Factors | 2022 |
High fructose-induced skeletal muscle insulin resistance could be alleviated by berberine via AMPD1 and ADSL.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylosuccinate Synthase; AMP-Activated Protein Kinases; Animals; Berberine; Insulin; Insulin Resistance; Muscle, Skeletal; Rats | 2023 |
AMPD2 plays important roles in regulating hepatic glucose and lipid metabolism.
Topics: Adenosine Monophosphate; AMP Deaminase; Animals; Cholesterol; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Insulin Resistance; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Obesity | 2023 |
Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinase Kinases; Animals; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Humans; Insulin Resistance; Liver; Male; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Inbred Strains; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Antirheumatic Agents; Blotting, Western; Body Composition; Diet, High-Fat; Female; Glucose Clamp Technique; GTP Phosphohydrolases; Immunoprecipitation; Infliximab; Insulin Resistance; Lipid Metabolism; Locomotion; Mice; Mice, Knockout; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle, Skeletal; Nerve Tissue Proteins; Obesity; Oxidation-Reduction; Tumor Necrosis Factor-alpha | 2017 |
Modified Si-Miao-San inhibits inflammation and promotes glucose disposal in adipocytes through regulation of AMP-kinase.
Topics: 3T3-L1 Cells; Adenosine Monophosphate; Adenylate Kinase; Adipocytes; Animals; Atractylodes; Coix; Coptis; Diabetes Mellitus; Drugs, Chinese Herbal; Glucose; Glucose Transporter Type 4; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; NF-kappa B; Phellodendron; Phosphatidylinositol 3-Kinases; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-akt; Signal Transduction | 2014 |
Irisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism.
Topics: Adenosine Monophosphate; Adipocytes; AMP-Activated Protein Kinases; Animals; Constitutive Androstane Receptor; Diet, High-Fat; Fibronectins; Gluconeogenesis; Glucose; Insulin Resistance; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Nuclear Reactors; Obesity; Receptors, Cytoplasmic and Nuclear; RNA, Messenger | 2016 |
Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Topics: Adenosine Monophosphate; Adenylate Kinase; Allosteric Site; AMP-Activated Protein Kinases; Animals; Binding Sites; Diabetes Mellitus, Type 2; Fatty Liver; Fructose; Gene Silencing; Glucose; Humans; Insulin Resistance; Lipogenesis; Liver; Metabolic Syndrome; Models, Theoretical; Phosphorylation; Portal Vein; Pyruvaldehyde; Stochastic Processes; Uric Acid | 2016 |
Crosstalk between the AMP-activated kinase and insulin signaling pathways rescues murine blastocyst cells from insulin resistance.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Blastocyst; Blotting, Western; Cell Line; Deoxyglucose; Enzyme Activation; Female; Hypoglycemic Agents; Insulin; Insulin Resistance; Mice; Phenformin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Ribonucleosides; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Signal Transduction | 2008 |
"Blinding" of AMP-dependent kinase by methylglyoxal: a mechanism that allows perpetuation of hepatic insulin resistance?
Topics: Adenosine Monophosphate; Insulin Resistance; Liver; Protein Binding; Protein Kinases; Pyruvaldehyde | 2009 |
Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylate Kinase; Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Adult; Amino Acid Substitution; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Bariatric Surgery; Biguanides; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Insulin Resistance; Lipolysis; Overweight; Patient Selection; Ribonucleotides; Serine; Thiazolidinediones; Threonine | 2010 |
The plasma 5'-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice.
Topics: Adenosine; Adenosine Monophosphate; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glycogenolysis; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Muscle, Skeletal; Necrosis; Protein Isoforms; Receptors, Purinergic P1 | 2012 |
[Physiological roles of AMP-activated protein kinase (AMPK)].
Topics: Adenosine Monophosphate; Adrenergic alpha-Antagonists; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Energy Metabolism; Enzyme Activation; Gluconeogenesis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Isoenzymes; Mice; Mice, Knockout; Models, Biological; Protein Kinases; Protein Subunits; Ribonucleotides; Sympathetic Nervous System | 2003 |
Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.
Topics: Acetyl-CoA Carboxylase; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Diet; Dietary Fats; Glucose Intolerance; Hyperlipidemias; Insulin Resistance; Ion Channels; Leptin; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Proteins; Multienzyme Complexes; Muscle, Skeletal; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; RNA, Messenger; Stearoyl-CoA Desaturase; Triglycerides; Uncoupling Protein 1; Weight Loss | 2005 |
Berberine improves glucose metabolism through induction of glycolysis.
Topics: 3T3-L1 Cells; Adenosine Monophosphate; Adenosine Triphosphate; Adipocytes; AMP-Activated Protein Kinases; Animals; Berberine; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose; Glucose Intolerance; Glycolysis; Insulin Resistance; Lactic Acid; Male; Mice; Mitochondria; Multienzyme Complexes; Obesity; Oxygen Consumption; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar | 2008 |